Sun Pharmaceutical Industries Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
SUNPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Sun Pharma has informed the stock exchanges that its trading window will be closed starting 1 April 2026 and will reopen only 48 hours after the company declares its audited financial results for the financial year ending 31 March 2026. This is a standard compliance action under SEBI's Prohibition of Insider Trading Regulations. The date of the board meeting to approve the FY26 audited results will be communicated separately. The notice has been signed by Anoop Deshpande, Company Secretary and Compliance Officer.
This is a routine regulatory filing and not a material business event. It does not affect the stock price directly, but it signals that the FY26 audited earnings announcement is approaching. Insiders and designated employees cannot trade in Sun Pharma shares during the closed window, which is standard practice ahead of results.